USP7 and acute myeloid leukemia: Furthermore, there is evidence that USP7 inhibition can selectively target acute myeloid leukemia (AML) cells while having minimal effects on normal cells.[35] This selectivity is likely due to the specific roles of USP7 in regulating pathways and proteins that are aberrantly activated in cancer cells but not in normal cells.